Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 03.08.2026 CPQ IE00BFD2H405 6,400,002.00 USD 397,875,483.10 62.168  ...

LONDON--(BUSINESS WIRE)--  03-August-2026 Issue: Mitsubishi HC Capital UK Plc Series 953 XS3176435785 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 11-May-2026 Date To: 10-August-2026 Record Date: 07-August-2026 Value Date: 10-August-2026 Benchmark Rate: 3.62482% Margin: 0.45% Total Rate: 4.07482% Floor: 0% Number of Days: 91 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: USD 3...

SAN DIEGO--(BUSINESS WIRE)--LabPMM®, una filiale di Invivoscribe®, ha annunciato oggi la disponibilità a livello globale del suo nuovo servizio di valutazione della malattia residua misurabile (MRD) KMT2A. Il servizio di PCR digitale ad alta sensibilità è a disposizione di operatori sanitari, ricercatori clinici e partner biofarmaceutici attraverso la rete globale di laboratori di LabPMM; negli Stati Uniti sono disponibili test accreditati CAP/CLIA. Il servizio risponde alla crescente esigenza...

SAN DIEGO--(BUSINESS WIRE)--LabPMM®, filiale d’Invivoscribe®, a annoncé aujourd’hui la mise à disposition mondiale de son nouveau service de dépistage de la maladie résiduelle mesurable (MRM) KMT2A. Ce service de PCR numérique hautement sensible est accessible aux professionnels de santé, aux chercheurs cliniques et aux partenaires biopharmaceutiques via le réseau mondial de laboratoires de LabPMM, les tests étant accrédités CAP/CLIA aux États-Unis. Ce service répond à un besoin croissant de su...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--VivaMed BioPharma today announced the formation of its Board of Directors, bringing together leaders in healthcare delivery, pharmaceutical research and manufacturing, public-company leadership, and corporate governance to guide the company’s next phase of growth.The Board will provide strategic oversight as VivaMed advances its mission to transform healthcare through innovative solutions that improve patient outcomes and expand access to high-quality care. It...

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) Important Notice to Shareholders of the Company Dividend Announcement 4 August 2026 Dividend announcement with regard to the following Funds of the Company The Board of Directors wishes to inform Shareholders that a dividend per share for certain Classes of Shares and Funds will be paid, as set out be...

LONDON--(BUSINESS WIRE)--  Please disregard the Important Notice of Dividend Announcement to shareholder of Xtrackers (IE) PLC announcement released at 14:02 BST on 04 Aug 2026. The full corrected version is shown below. Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) Important Notice to Shareholders of the Company Dividend Announcement 4 August 2026 Dividend announcement wi...

SAN FRANCISCO--(BUSINESS WIRE)--Collov Labs, an AI lab advancing foundational visual AI technology, today launched NewEyes AI, an app built on the company's proprietary visual AI platform, delivering the most advanced visual AI on the market today in an app that allows users to point their smartphone camera at a scene and have AI agents take the next step for them, turning a photo into a finished task rather than just an answer. The launch follows Collov Labs' $23M Series A earlier this year, w...

LONDON--(BUSINESS WIRE)--  Please disregard the Important Notice of Dividend Announcement to shareholder of Xtrackers (IE) PLC announcement released at 09:45 BST on 04 Aug 2026. The full corrected version is shown below. Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) Important Notice to Shareholders of the Company Dividend Announcement 4 August 2026 Dividend announcement wi...

LONDON--(BUSINESS WIRE)--  Please disregard the Important Notice of Dividend Announcement to shareholder of Xtrackers (IE) PLC announcement released at 09:37 BST on 04 Aug 2026. The full corrected version is shown below. Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) Important Notice to Shareholders of the Company Dividend Announcement 4 August 2026 Dividend announcement wi...